Blood Coagulation Analyzers Sales

Blood Coagulation Analyzers Sales Market Outlook

The global Blood Coagulation Analyzers market was valued at approximately USD 3.5 billion in 2023 and is projected to reach around USD 5.5 billion by 2033, growing at a robust CAGR of 4.5% during the forecast period of 2025 to 2035. Factors driving this growth include the increasing prevalence of blood disorders such as hemophilia and thrombosis, rising demand for advanced diagnostic technologies, and the growing geriatric population which is more susceptible to coagulation-related diseases. Moreover, technological advancements in coagulation analyzers that allow for faster and more accurate results are further propelling market growth. The increased awareness about the importance of timely diagnosis and monitoring of coagulation disorders is also playing a critical role in expanding the market. As healthcare systems worldwide focus on enhancing patient outcomes, the demand for blood coagulation analyzers is expected to rise significantly.

Growth Factor of the Market

The Blood Coagulation Analyzers market is experiencing significant growth due to several emerging factors. Primarily, the increasing incidence of cardiovascular diseases and conditions requiring anticoagulation therapy is leading to a higher demand for coagulation testing. Moreover, advancements in technology, including the development of portable and user-friendly devices for point-of-care testing, are making it easier for healthcare providers to monitor blood coagulation levels in real-time. Additionally, the rise in awareness regarding the availability of advanced diagnostic tools has prompted healthcare professionals to adopt these technologies more readily. The shift toward personalized medicine, where treatments are tailored based on patient-specific data and genetic information, is also driving demand, as these analyzers can provide critical information for effective treatment strategies. Furthermore, investments by key players in research and development to innovate and improve existing coagulation testing methodologies continue to bolster market growth.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 4.5% from 2025 to 2035.
• North America is expected to hold the largest market share due to advanced healthcare infrastructure.
• Technological innovations in coagulation analyzers are enhancing diagnostic accuracy.
• Point-of-care testing analyzers are gaining popularity due to their convenience in clinical settings.
• Growing awareness of blood disorders is driving the demand for coagulation testing.

By Product Type

Clinical Laboratory Analyzers :

Clinical Laboratory Analyzers represent a significant segment of the Blood Coagulation Analyzers market, primarily utilized in centralized laboratories for comprehensive testing. These analyzers are designed to handle a high volume of tests with superior precision and accuracy. They utilize various methodologies, such as optical and mechanical detection, to measure coagulation parameters, enabling healthcare professionals to diagnose conditions like hemophilia and thrombosis effectively. The ability to process multiple samples simultaneously also enhances the efficiency of laboratory operations, making these analyzers a preferred choice in large diagnostic laboratories. With ongoing innovations aimed at increasing throughput and minimizing human errors, the demand for clinical laboratory analyzers is expected to continue its upward trajectory, supported by the growing prevalence of blood-related disorders.

Point-of-Care Testing Analyzers :

Point-of-Care Testing (POCT) Analyzers have gained traction in the Blood Coagulation Analyzers market due to their convenience and the rapid results they provide. These portable devices allow healthcare professionals to conduct coagulation tests at the patient's bedside or in outpatient settings, significantly reducing the time between testing and diagnosis. This capability is particularly valuable in emergency situations where rapid decision-making can be critical. POCT analyzers are designed for easy operation and require minimal training, making them accessible for a wide range of healthcare settings. Their ability to provide immediate feedback on coagulation status is driving their adoption, particularly in emergency departments, outpatient clinics, and by general practitioners, thus contributing to the overall growth of the market.

Whole Blood Hemostasis Analyzers :

Whole Blood Hemostasis Analyzers are specialized devices designed to evaluate the hemostatic status of patients by analyzing whole blood samples. These analyzers offer a comprehensive evaluation of various coagulation factors and can provide information about clot formation and stability. The growing interest in personalized medicine and tailored anticoagulant therapy is propelling the market for whole blood hemostasis analyzers, as they enable healthcare providers to make informed decisions based on individual patient profiles. Moreover, the ability to conduct multiple tests in a single session increases the efficiency of the diagnostic process, making these analyzers a valuable asset in critical care and surgical environments. As more healthcare facilities adopt these advanced technologies, the market for whole blood hemostasis analyzers is expected to expand accordingly.

Platelet Function Analyzers :

Platelet Function Analyzers are essential tools in assessing platelet activity and functionality, which play a vital role in blood coagulation processes. These devices are crucial for diagnosing conditions related to bleeding disorders and monitoring patients on antiplatelet therapies. By providing comprehensive information on platelet aggregation and responsiveness to various stimuli, these analyzers facilitate the development of personalized treatment plans for patients with cardiovascular conditions. The increasing recognition of the importance of platelet function testing in managing anticoagulation therapy is driving demand for these specialized analyzers. With advancements in technology enhancing the precision and speed of testing, the market for platelet function analyzers is poised for significant growth in the coming years.

Thrombin Generation Analyzers :

Thrombin Generation Analyzers are innovative devices designed to measure the generation of thrombin, a key enzyme in the coagulation process. These analyzers provide valuable insights into the coagulation pathway and help assess the risk of thromboembolic events in patients. The growing understanding of thrombin's role in various coagulation disorders is leading to increased demand for these specialized analyzers. Additionally, they are becoming integral in managing patients undergoing anticoagulant therapy, as they offer a means to monitor and adjust treatment based on individual responses. The rise in research focusing on thrombin's implications in various diseases is further driving the market for thrombin generation analyzers, setting a positive growth outlook for this segment.

By Application

Hemostasis Testing :

Hemostasis Testing is a critical application area within the Blood Coagulation Analyzers market, focusing on evaluating the blood's ability to clot. This testing is pivotal in diagnosing various coagulation disorders, including hemophilia, Von Willebrand disease, and thrombophilia. The increase in surgical procedures and trauma cases, necessitating quick hemostatic assessment, is driving demand for accurate and efficient hemostasis testing solutions. Furthermore, the rise in awareness regarding the need for pre-operative and post-operative coagulation assessments is propelling the adoption of blood coagulation analyzers designed for this purpose. Innovations in testing methodologies and improvements in turnaround times for results are also enhancing the relevance of hemostasis testing in clinical settings, ensuring its vital role in patient management.

Platelet Function Testing :

Platelet Function Testing is increasingly recognized for its importance in understanding platelet activity and its implications in thrombotic conditions. As the prevalence of cardiovascular diseases rises, the need for accurate assessment of platelet function is becoming paramount. This testing is essential not just in the diagnosis of bleeding disorders but also in monitoring patients receiving antiplatelet therapies. Blood coagulation analyzers that specialize in platelet function testing enable clinicians to tailor their treatment strategies effectively. The growing emphasis on personalized medicine and the need for precise monitoring in interventional cardiology practices are further driving the demand for analyzers focused on platelet function testing, highlighting its critical role in modern healthcare.

Thrombophilia Testing :

Thrombophilia Testing plays a crucial role in identifying patients with an increased risk of thrombosis due to inherited or acquired conditions. This application is gaining traction as the awareness of thrombotic disorders among healthcare providers and patients increases. Blood coagulation analyzers that facilitate thrombophilia testing are vital in the timely diagnosis and management of these conditions. The growing incidence of venous thromboembolism cases and the need for effective monitoring of patients at risk contribute to the expanding market for thrombophilia testing solutions. Moreover, advancements in genetic testing methodologies are enhancing the accuracy and efficiency of thrombophilia evaluations, driving further investment and development in this area.

Liver Disease :

Liver Disease is another significant application area for blood coagulation analyzers, as liver function directly affects the coagulation cascade. Conditions like cirrhosis and hepatitis disrupt normal hemostasis, making coagulation testing essential for monitoring and managing these patients. As the prevalence of liver diseases continues to rise globally, there is an increasing demand for accurate coagulation assessment tools. Blood coagulation analyzers that can evaluate liver function indicators alongside coagulation parameters are becoming invaluable in clinical practice. Enhanced understanding of the relationship between liver health and coagulation status is prompting a more integrated approach to testing, further propelling the market for analyzers tailored for liver disease applications.

Others :

In addition to the primary applications mentioned, there are several other emerging areas where blood coagulation analyzers are being utilized. These include applications in research settings, where understanding blood coagulation mechanisms is critical for developing new therapeutic approaches. Additionally, the analyzers play a role in sports medicine, where monitoring athletes’ coagulation levels can provide insights into their physical condition and risks of injury. The versatility of blood coagulation analyzers for various applications beyond traditional clinical settings is broadening their market appeal. As healthcare continues to evolve, the significance of these analyzers in diverse fields is likely to increase, opening new avenues for growth and innovation within the market.

By Distribution Channel

Hospitals :

Hospitals represent a significant distribution channel for blood coagulation analyzers, accounting for a substantial share of the market. These facilities require advanced diagnostic equipment to manage various patient conditions effectively, particularly in emergency departments and intensive care units where timely coagulation assessments are critical. Hospitals invest in both centralized laboratory analyzers and point-of-care testing devices to enhance patient care and streamline workflows. The increasing number of surgical procedures performed in hospitals further drives the demand for reliable coagulation testing solutions, as accurate monitoring of coagulation status is essential for preventing complications. As hospital networks expand and healthcare systems focus on improving clinical outcomes, the role of hospitals as a distribution channel for blood coagulation analyzers is expected to grow steadily.

Diagnostic Centers :

Diagnostic Centers serve as a vital distribution channel for blood coagulation analyzers, catering to the rising demand for specialized testing services. These centers typically focus on providing accurate and efficient diagnostic services, and they invest in advanced coagulation testing technologies to attract physicians and patients. The convenience of standalone diagnostic centers, along with their capacity to conduct a broad range of tests, makes them increasingly popular among healthcare providers. Moreover, the growing trend of preventive healthcare encourages patients to seek testing services at diagnostic centers, further amplifying the need for blood coagulation analyzers. As these centers continue to enhance their service offerings and expand their capabilities, they will play a crucial role in the overall growth of the blood coagulation analyzers market.

Research Institutes :

Research Institutes are another important distribution channel for blood coagulation analyzers, particularly as the focus on understanding coagulation mechanisms and developing new treatments intensifies. These institutes utilize advanced coagulation testing technologies in various research projects, ranging from basic science studies to clinical trials. The demand for innovative solutions in research settings is driving investments in blood coagulation analyzers that offer high accuracy and reliability. Furthermore, collaborations between research institutes and healthcare organizations are on the rise, facilitating the exchange of knowledge and technology. As the need for research-driven insights into coagulation disorders grows, research institutes will continue to be a prominent distribution channel for blood coagulation analyzers, significantly impacting market dynamics.

Others :

The "Others" category encompasses various distribution channels, including specialty clinics, home healthcare agencies, and online platforms. Specialty clinics that focus on hematology or conditions requiring coagulation monitoring are increasingly adopting blood coagulation analyzers to provide comprehensive care. Home healthcare agencies are also beginning to leverage point-of-care testing devices, allowing healthcare providers to conduct tests in patients' homes for greater convenience. Additionally, the rise of e-commerce has facilitated the online sale of diagnostic equipment, including blood coagulation analyzers, expanding access to these vital tools. As the healthcare landscape continues to evolve, the diversity of distribution channels for blood coagulation analyzers is expected to broaden, providing more options for healthcare providers and patients alike.

By Region

The Blood Coagulation Analyzers market exhibits significant regional variations, with North America holding the largest market share estimated at around USD 1.5 billion in 2023. The region's advanced healthcare infrastructure, early adoption of innovative technologies, and a high prevalence of blood disorders contribute to its dominant position. The CAGR for this region is forecasted to be around 4.2% from 2025 to 2035, driven by continuous investments in research and development by key players. Europe follows closely, with a market size of approximately USD 1.2 billion, primarily supported by the increasing focus on personalized medicine and the growing aging population, which is more susceptible to coagulation disorders. Countries such as Germany, France, and the UK are expected to lead market growth within Europe due to their robust healthcare systems and high demand for advanced diagnostic tools.

In the Asia Pacific region, the Blood Coagulation Analyzers market is projected to witness significant growth, with a market size of around USD 900 million in 2023, reflecting a CAGR of 5.0% during the forecast period. Factors such as rising healthcare expenditure, increasing awareness about blood disorders, and enhancements in laboratory infrastructure are driving market expansion in countries like China, India, and Japan. Additionally, Latin America and the Middle East and Africa regions present opportunities for growth, albeit at a slower pace. The overall market size for Latin America is approximately USD 300 million, while the Middle East and Africa hold a share of around USD 200 million. As healthcare facilities improve and access to diagnostic services increases in these regions, the demand for blood coagulation analyzers is expected to rise steadily.

Opportunities

The Blood Coagulation Analyzers market is ripe with opportunities, particularly in the realm of technological advancements and innovations. The emergence of point-of-care testing devices presents a significant opportunity for companies involved in this market, as these devices cater to the increasing need for rapid diagnostic testing in various clinical settings. By investing in research and development to enhance the capabilities of point-of-care analyzers, manufacturers can meet the growing demand for immediate test results, which is crucial in emergency situations. Additionally, the integration of artificial intelligence and machine learning in coagulation analyzers can offer more precise data interpretation and predictive analytics, thus improving patient outcomes. These advancements not only boost efficiency but also open doors for new applications of coagulation testing in diverse healthcare environments, creating a pathway for sustained growth in the market.

Another opportunity lies in the growing emphasis on preventive healthcare and personalized medicine. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for accurate coagulation testing will continue to rise. This shift towards personalized medicine can lead to higher adoption rates of advanced coagulation analyzers, particularly those that offer comprehensive analysis capabilities. Moreover, expanding access to healthcare in emerging economies presents a substantial opportunity for market players. By developing cost-effective and easy-to-use coagulation analyzers, companies can penetrate these markets and cater to the rising demand for diagnostic testing. Overall, leveraging technological advancements and focusing on personalized approaches could significantly enhance market prospects for blood coagulation analyzers.

Threats

Despite the promising growth trajectory of the Blood Coagulation Analyzers market, several threats could impede its progress. One of the primary challenges is the regulatory landscape, which can vary significantly across regions. Stricter regulations surrounding medical devices and diagnostics may lead to increased compliance costs and extended timelines for product development and approval. These challenges can deter smaller players from entering the market and may slow down innovation. Furthermore, the rise in competition from alternative diagnostic methods, such as molecular diagnostics, poses a threat to the traditional blood coagulation analyzers market. As healthcare providers explore and adopt new technologies, the demand for conventional testing methods may diminish, leading to potential market share losses for existing players.

Another significant threat is the economic variability that affects healthcare funding and investments. In times of economic downturns, healthcare budgets may be cut, leading to reduced spending on advanced diagnostic technologies. This can directly impact the growth of the blood coagulation analyzers market, as hospitals and diagnostic centers may delay or forgo investments in new equipment. Furthermore, the ongoing challenges posed by global pandemics, such as COVID-19, have highlighted vulnerabilities in supply chains and operational continuity. Disruptions caused by such events can lead to shortages of essential components, thereby affecting production timelines and availability of blood coagulation analyzers. Ensuring a stable supply chain and adapting to changing market conditions will be critical for companies operating in this space.

Competitor Outlook

• Roche Diagnostics
• Siemens Healthineers
• Abbott Laboratories
• Beckman Coulter, Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Horiba Medical
• Grifols S.A.
• Bio-Rad Laboratories, Inc.
• Ortho Clinical Diagnostics
• Agilent Technologies, Inc.
• AccuTech, LLC
• Mindray Medical International Limited
• Medtronic plc
• HemoSonics, LLC

The competitive landscape of the Blood Coagulation Analyzers market is characterized by the presence of several key players who continually strive to innovate and expand their market reach. Leading companies such as Roche Diagnostics and Siemens Healthineers dominate the market due to their extensive product portfolios and strong brand recognition. These players invest heavily in research and development to introduce advanced coagulation testing technologies that cater to the evolving needs of healthcare providers. The emphasis on technological innovation, particularly in point-of-care testing and integration with laboratory information systems, distinguishes these companies from their competitors. Additionally, strategic partnerships and collaborations with healthcare organizations allow these firms to enhance their service offerings and maintain a competitive edge.

Other notable companies, including Abbott Laboratories and Beckman Coulter, are also making significant strides in the market through product development and targeted marketing strategies. Abbott Laboratories, known for its robust point-of-care testing devices, is focusing on expanding its product range to include more comprehensive coagulation analyzers that meet the demands of various clinical applications. Meanwhile, Beckman Coulter is leveraging its expertise in laboratory automation to provide integrated solutions that enhance the efficiency of blood coagulation testing in large laboratory settings. These companies are continuously exploring mergers and acquisitions to strengthen their market position and drive growth in the blood coagulation analyzers segment.

In addition to these major players, smaller and emerging companies such as HemoSonics and AccuTech are carving their niche within the market. These companies focus on innovative solutions and specialized applications in coagulation testing, allowing them to differentiate themselves from larger competitors. HemoSonics, for instance, is renowned for its point-of-care testing solutions that provide rapid insights into hemostasis, catering to critical care environments. Meanwhile, AccuTech emphasizes cost-effective solutions that allow smaller healthcare facilities to access high-quality coagulation testing equipment. The overall competitive landscape is marked by diversification, where companies are exploring various avenues to enhance their product offerings and respond to the changing demands of the healthcare market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Grifols S.A.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 AccuTech, LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Horiba Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 HemoSonics, LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sysmex Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Beckman Coulter, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ortho Clinical Diagnostics
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Mindray Medical International Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Coagulation Analyzers Sales Market, By Application
    • 6.1.1 Hemostasis Testing
    • 6.1.2 Platelet Function Testing
    • 6.1.3 Thrombophilia Testing
    • 6.1.4 Liver Disease
    • 6.1.5 Others
  • 6.2 Blood Coagulation Analyzers Sales Market, By Product Type
    • 6.2.1 Clinical Laboratory Analyzers
    • 6.2.2 Point-of-Care Testing Analyzers
    • 6.2.3 Whole Blood Hemostasis Analyzers
    • 6.2.4 Platelet Function Analyzers
    • 6.2.5 Thrombin Generation Analyzers
  • 6.3 Blood Coagulation Analyzers Sales Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Diagnostic Centers
    • 6.3.3 Research Institutes
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Blood Coagulation Analyzers Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Coagulation Analyzers Sales market is categorized based on

By Product Type

• Clinical Laboratory Analyzers
• Point-of-Care Testing Analyzers
• Whole Blood Hemostasis Analyzers
• Platelet Function Analyzers
• Thrombin Generation Analyzers

By Application

• Hemostasis Testing
• Platelet Function Testing
• Thrombophilia Testing
• Liver Disease
• Others

By Distribution Channel

• Hospitals
• Diagnostic Centers
• Research Institutes
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Roche Diagnostics
• Siemens Healthineers
• Abbott Laboratories
• Beckman Coulter, Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Horiba Medical
• Grifols S.A.
• Bio-Rad Laboratories, Inc.
• Ortho Clinical Diagnostics
• Agilent Technologies, Inc.
• AccuTech, LLC
• Mindray Medical International Limited
• Medtronic plc
• HemoSonics, LLC